Serum Uric Acid in Women with Preeclampsia and its Relation to Perinatal and Maternal Outcomes

Dileen Anwar  Sadeeq; Maeda Yousif  Shamdeen; Jinan Nori  Hasan

doi:10.56056/amj.2024.289

Authors

Dileen Anwar Sadeeq Senior house officer at Duhok Obstetrics and Gynecology Teaching Hospital
Maeda Yousif Shamdeen Professor of Obstetrics and Gynecology teaching hospital
Jinan Nori Hasan Duhok Obstetrics and Gynecology teaching hospital

DOI:

https://doi.org/10.56056/amj.2024.289

Keywords:

Maternal Outcomes, Neonatal Outcomes, Preeclampsia, Uric acid

Abstract

Background and objective: Preeclampsia is a dangerous, progressive condition that is linked to maternal and neonatal death and morbidity. The purpose of this study was to determine the association between serum uric acid levels in preeclampsia with maternal and fetal outcomes.

Method: A case-control study was conducted on 300 women delivered at the labour room of Duhok Obstetrics and Gynecology Hospital, from 1st of April 2021 to 1st of April 2022. The study participants were divided into two groups, pregnant women with preeclampsia and normotensive women. The serum uric acid levels of these women were estimated with the impact on fetal and mother outcomes.

Results: There was a highly significant association between preeclamptic and normotensive women in relation to mean serum uric acid (5.862 ±1.416) mg/dL and (3.570 ±0.982) mg/dL respectively. A highly significant association was seen between uric acid test levels and maternal eclamptic fit, HELLP syndrome and admission to intensive care unit. A highly significant association also seen with newborn birth weight, APGAR scores and admission to neonatal intensive care unit.

Conclusion: The current study demonstrates a significant raise in serum uric acid level in preeclamptic women and associated with adverse perinatal and maternal outcomes.

Downloads

Download data is not yet available.

References

Cunnigham FG, Gant NF. Hypertensive disorders in pregnancy. In: Gilstrap LC, Hanth JC, Wenstrom KD, editors. Williams Obstertrics, 2014, 25th Ed. London: McGraw-Hill, 710-745.

Ryu A, Cho NJ, Kim YS, Lee EY. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Medicine. 2019;98(18): e15462.

NICE Guidelines on Pre-Eclampsia (2020). Available from: https://action-on-pre-eclampsia.org.uk/wp-content/uploads/2020/01/NICE_guidance_on-Pre-eclampsia_VB2020.pdf/

Diwan J, Shah C, Dixit R, Anand AK. A Comparative Study of Serum Uric Acid Level in Normal Pregnancy, and Pregnancy Induced Hypertension. Int J Med Pub H. 2011;1(1):39-4.

Meena R, Pachori P, Chaudhary S, Chandrakanta. Level of serum uric acid in patients with preeclampsia compared to controls and its relation to feto-maternal outcome. Int J Reprod Contracept Obstet Gynecol. 2019; 8(6):2471-4.

Chen C, Lü JM, Yao Q. Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview. Med Sci Monit. 2016; 17(22):2501-12.

Gherghina M, Peride I, Tiglis M, Neagu TP, Niculae A, Checherita IA. Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment. Int J Mol Sci. 2022; 23(6):3188.

Livingston JR, Payne B, Brown M, Roberts J, Cote A, Magee L et al. Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia. J Obstet Gynaecol Can. 2014; 36(10):870-7.

Zangana JM, Hamadamen AI. Serum Uric Acid as a Predictor of Perinatal Outcome in Women with Pre-Eclampsia. IJMRHS. 2018; 7(3):168-74.

Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009; 114(6):1326-31.

Adams, M.M., Alexander, G.R., Kirby, R.S., Wingate, M.S., 2010. Perinatal Epidemiology for Public Health Practice. Springer Science & Business Media.

Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, et al., on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. BJOG 2016; 124: e106– e149.

American College of Obstetricians and Gynecologists (ACOG): Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020; 135(6):e237–e260, 2020.

Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension. 2011; 58(4):704-8.

Kristensen JH, Basit S, Wohlfahrt J, Damholt MB, Boyd HA. Pre-eclampsia and risk of later kidney disease: nationwide cohort study. BMJ. 2019; 365: l; 1516.

Bainbridge SA, Roberts JM. Uric Acid as a Pathogenic Factor in Preeclampsia. Placenta. 2008; 29(1): 67–72.

Williams KP, Galerneau F. The Role of Serum Uric Acid as a Prognostic Indicator of the Severity of Maternal and Fetal Complications in Hypertensive Pregnancies. J Obstet Gynaecol Can. 2002; 24(8):628-32.

Audu N, Gadzama A. Effects of Hyperuricaemia on Pre-eclamptic, Eclamptic Patients and their Foetal Outcome. European j. biomed. pharm. sci. 2016; 3(9): 85-8.

Wu Y, Xiong X, Fraser WD, Luo ZC. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. Am J Hypertens. 2012; 25(6):711-7.

Akter S, Sultana S, Dabee SR. Association of Hyperuricaemia with Perinatal Outcome in Pregnancy Induced Hypertension. J. Bangladesh Coll. Phys. Surg. 2014;32(3), 124–9.

Zangana JM, Hamadamen AI. Serum Uric Acid as a Predictor of Perinatal Outcome in Women with Pre-Eclampsia. IJMRHS. 2018;7(3):168-74.

Priya AR, Jeyapriya K, Kannan NS. Accuracy of serum uric acid predicting complication of preeclampsia. Int J Cur Res Rev. 2016;8(5):13-21.

Ugwuanyi RU, Chiege IM, Agwu FE, Eleje GU, Ifediorah NM. Association between Serum Uric Acid Levels and Perinatal Outcome in Women with Preeclampsia. Obstet Gynecol Int. 2021; 2021:1-8.